- 【Updated on May 12, 2025】 Integration of CiNii Dissertations and CiNii Books into CiNii Research
- Trial version of CiNii Research Knowledge Graph Search feature is available on CiNii Labs
- Suspension and deletion of data provided by Nikkei BP
- Regarding the recording of “Research Data” and “Evidence Data”
CLINICAL EXPERIENCE WITH TRANSURETHRAL RESECTION OF BLADDER TUMOR (TUR-Bt) GUIDED BY PHOTODYNAMIC DIAGNOSIS (PDD)
-
- Inoue Keiji
- Department of Urology, Kochi Medical School
-
- Kuno Takahira
- Department of Urology, Kochi Medical School
-
- Fukuhara Hideo
- Department of Urology, Kochi Medical School
-
- Hamaguchi Takuya
- Department of Urology, Kochi Medical School
-
- Fukata Satoshi
- Department of Urology, Kochi Medical School
-
- Karashima Takashi
- Department of Urology, Kochi Medical School
-
- Kamada Masayuki
- Department of Urology, Kochi Medical School
-
- Shuin Taro
- Department of Urology, Kochi Medical School
-
- Sakakura Naoki
- Department of Urology, Kochi National Hospital
-
- Kasahara Kotaro
- Department of Urology, Kochi National Hospital
-
- Watanabe Hironobu
- Department of Urology, Kochi National Hospital
-
- Kozai Tetsuo
- Department of Urology, Chikamori Hospital
-
- Yasuda Masaharu
- Department of Urology, Chikamori Hospital
-
- Kataoka Shinichi
- Department of Urology, Chikamori Hospital
-
- Tanimura Masanobu
- Department of Urology, Chikamori Hospital
-
- Kurabayashi Atsushi
- Department of Pathology, Kochi Medical School
-
- Furihata Mutsuo
- Department of Pathology, Kochi Medical School
Bibliographic Information
- Other Title
-
- 光力学診断補助下経尿道的膀胱腫瘍切除術の臨床経験
- コウリキガク シンダン ホジョ カケイ ニョウドウテキ ボウコウ シュヨウ セツジョジュツ ノ リンショウ ケイケン
Search this article
Description
(Purpose) To report our clinical experience regarding transurethral resection of bladder tumor (TUR-Bt) guided by photodynamic diagnosis (PDD) with intravesical instillations of 5-aminolevulinic acid (ALA) and to assess the usefulness of the therapeutic method.<br> (Materials and methods) TUR-Bt guided by PDD was performed in 57 patients of which 47 were men and 10 women with a median age of 74.3 years (range 45-90), 36 were primary cases and 21 were recurrent cases with non-muscle invasive bladder cancer. Two to two and half hours prior to endoscopy 1.5 g ALA dissolved in 50 ml of 8.4% sodium hydrogen carbonate (NaHCO3) solution was instilled intravesically. For fluorescence excitation a blue light source (D-LIGHT System, Karl Storz Endoscopy Japan K.K.) was used. The tumorous lesions under white light guidance and the lesion with fluorescent excitation under blue (fluorescence) light guidance were taken by cold cup as a biopsy and also resected sequentially. To evaluate the accuracy of PDD, the levels in images of the ALA-induced fluorescence were compared with the pathological results. To evaluate the availability of TUR-Bt guided by PDD, survival Analysis regarding vesical recurrence was retrospectively examined compared to the cases underwent conventional TUR-Bt under white light guidance. Moreover, in these cases, multivariate analysis using Cox proportional-hazards model was performed to detect the clinico-pathological factor independently contribute to improving prognosis.<br> (Results) In the 301 specimens obtained from 57 patients, the sensitivity and specificity of PDD were 92.5% and 60.1%, whereas the sensitivity and specificity of conventional endoscopic examination under white light guidance were 81.6% and 79.5%, respectively. Median follow-up period was 19.1 (range 8.6-49.9) months in 57 patients underwent TUR-Bt guided by PDD. Eight of 57 patients recurred and recurrence-free survival rate was 88.2±0.1% (at 12 months) and 76.2±0.1% (24-48 months). Median follow-up period was 49.9 (5.0-145.0) months in 149 patients underwent conventional TUR-Bt. Ninety-nine of 149 patients recurred and recurrence-free survival rate was 60.3±0.0% (12 months) and 31.6±0.0% (24-48 months). There was statistical significance in recurrence-free survival rate between these 2 therapeutic groups (p< 0.001). Moreover, multivariate analysis revealed the independent factor contribute to improving prognosis was only TUR-Bt guided by PDD (hazard ratio 0.279, p=0.001).<br> (Conclusion) It was suggested that TUR-Bt guided by PDD might reduce the risk of vesical recurrence in the early stage after operation of non-muscle invasive bladder cancer.<br>
Journal
-
- The Japanese Journal of Urology
-
The Japanese Journal of Urology 100 (7), 661-670, 2009
THE JAPANESE UROLOGICAL ASSOCIATION
- Tweet
Keywords
Details 詳細情報について
-
- CRID
- 1390001205055689984
-
- NII Article ID
- 110007482828
-
- NII Book ID
- AN00196577
-
- COI
- 1:STN:280:DC%2BD1MfitV2nug%3D%3D
-
- ISSN
- 18847110
- 00215287
-
- NDL BIB ID
- 10440607
-
- PubMed
- 19999130
-
- Text Lang
- ja
-
- Article Type
- journal article
-
- Data Source
-
- JaLC
- NDL Search
- Crossref
- PubMed
- CiNii Articles
- OpenAIRE
-
- Abstract License Flag
- Disallowed